No Data
No Data
Prelude to increased tariffs? The Trump administration has initiated a Section 232 investigation into pharmaceuticals and Semiconductors.
① The USA government disclosed on Monday that it has launched an investigation into the impact of imported Pharmaceuticals and Semiconductors on National Security; ② This is widely seen as a prelude to imposing tariffs on prescription drugs and Semiconductors, and it could further escalate the trade war initiated by the USA.
Building Product Companies Will Need Higher Prices to Offset Tariff Impact -- Market Talk
Building Products Firms, Homebuilders Face 'Significant' Earnings Risks From Tariffs, RBC Says
The FDA has suffered a severe blow as the Trump administration cuts positions in public health institutions, leading to a decline in stock prices of pharmaceutical industry companies.
On Tuesday, the Trump administration began a large-scale reduction of positions at USA public health Institutions.
Cantor Analyst rarely criticized the USA Secretary of Health, stating that "misguided decisions will backfire on the government's reputation," causing the Biotechnology Sector to plummet.
The financial services institution Cantor Fitzgerald's Biotechnology Analysts Josh Schimmer and Eric Schmidt rarely publicly criticized the leadership of USA Health Secretary Kennedy.
Crisis and Redemption: The Darkest Moment and Dawn of the Vaccine Industry.
The vaccine Industry is currently facing challenges, but its fate is not simply a one-way decline.